Broad-spectrum antimicrobial activity and improved stability of a D-Amino acid enantiomer of DMPC-10A, the designed derivative of dermaseptin truncates

Article

Zai, Y., Ying, Y., Ye, Z., Zhou, M., Ma, C., Shi, Z., Chen, X., Xi, X., Chen, T. and Wang, L. 2020. Broad-spectrum antimicrobial activity and improved stability of a D-Amino acid enantiomer of DMPC-10A, the designed derivative of dermaseptin truncates. Antibiotics. 9 (9), pp. 1-19. https://doi.org/10.3390/antibiotics9090627
TypeArticle
TitleBroad-spectrum antimicrobial activity and improved stability of a D-Amino acid enantiomer of DMPC-10A, the designed derivative of dermaseptin truncates
AuthorsZai, Y., Ying, Y., Ye, Z., Zhou, M., Ma, C., Shi, Z., Chen, X., Xi, X., Chen, T. and Wang, L.
Abstract

DMPC-10A (ALWKKLLKK-Cha-NH2) is a 10-mer peptide derivative from the N-terminal domain of Dermaseptin-PC which has shown broad-spectrum antimicrobial activity as well as a considerable hemolytic effect. In order to reduce hemolytic activity and improve stability to endogenous enzymes, a D-amino acid enantiomer (DMPC-10B) was designed by substituting all L-Lys and L-Leu with their respective D-form amino acid residues, while the Ala1 and Trp3 remained unchanged. The D-amino acid enantiomer exhibited similar antimicrobial potency to the parent peptide but exerted lower cytotoxicity and hemolytic activity. Meanwhile, DMPC-10B exhibited remarkable resistance to hydrolysis by trypsin and chymotrypsin. In addition to these advantages, DMPC-10B exhibited an outstanding antibacterial effect against Methicillin-resistant Staphylococcus aureus (MRSA) and Klebsiella pneumoniae using the Galleria mellonella larva model and displayed synergistic activities with gentamicin against carbapenem-resistant K. pneumoniae strains. This indicates that DMPC-10B would be a promising alternative for treating antibiotic-resistant pathogens.

Keywordsantimicrobial peptide, D-amino acid, protease stability, Galleria mellonella larva model
PublisherMDPI
JournalAntibiotics
ISSN2079-6382
Publication dates
Online21 Sep 2020
Print21 Sep 2020
Publication process dates
Deposited23 Sep 2020
Submitted26 Aug 2020
Accepted17 Sep 2020
Output statusPublished
Publisher's version
License
Copyright Statement

© 2020 by the authors.
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.

Additional information

This article belongs to the Special Issue Synthesis and Utility of Antimicrobial Peptides

Digital Object Identifier (DOI)https://doi.org/10.3390/antibiotics9090627
LanguageEnglish
Permalink -

https://repository.mdx.ac.uk/item/89146

Log in to edit

Download files

Publisher's version
antibiotics-09-00627-v2.pdf
antibiotics-09-00627.xml
additional-files.zip
License: CC BY 4.0

  • 125
    total views
  • 108
    total downloads
  • 3
    views this month
  • 1
    downloads this month

Export as

Related outputs

Molecular dynamics of PU.1 and annexin A1 in acute promyelocytic leukaemia cells following ATRA/ATO therapy
Akmandor, T. and Shi, Z. 2026. Molecular dynamics of PU.1 and annexin A1 in acute promyelocytic leukaemia cells following ATRA/ATO therapy. British Society for Haematology (BSH) 66th Annual Scientific Meeting 2026 . Liverpool, UK 18 - 21 Apr 2026 Wiley.
Transcriptional modulation of differentiation-associated markers during ATRA and ATO treatment in acute promyelocytic leukaemia cells
Akmandor, T., Tuduwage, D., Mire, M. and Shi, Z. 2026. Transcriptional modulation of differentiation-associated markers during ATRA and ATO treatment in acute promyelocytic leukaemia cells. British Society for Haematology (BSH) 66th Annual Scientific Meeting 2026 . Liverpool, UK 18 - 21 Apr 2026 Wiley.
Assessing flavones’ selective modulation of cell signalling in acute myeloid leukaemia and non-cancerous cells in vitro [Presentation]
Punev, I., Vu, M., Devo, P., Appiah, S. and Shi, Z. 2025. Assessing flavones’ selective modulation of cell signalling in acute myeloid leukaemia and non-cancerous cells in vitro [Presentation]. 2025 Middlesex University Postgraduate Researchers Summer Conference. Middlesex University London, UK 17 - 18 Jun 2025
Selective modulation of cell signalling by flavones in acute myeloid leukaemia and non-cancerous peripheral blood cells in vitro - preliminary study
Punev, I., Vu, M., Devo, P., Appiah, S. and Shi, Z. 2025. Selective modulation of cell signalling by flavones in acute myeloid leukaemia and non-cancerous peripheral blood cells in vitro - preliminary study. 7th International Conference: Acute Myeloid Leukemia "Molecular and Translational": Advances in Biology and Treatment. Estoril, Portugal 16 - 18 Oct 2025
Structure-related cytotoxic effects of flavones and doxorubicin in chronic myeloid leukaemia and non-cancerous cells in vitro– a preliminary study [Abstract]
Punev, I., Vu, M., Devo, P., Shi, Z. and Appiah, S. 2025. Structure-related cytotoxic effects of flavones and doxorubicin in chronic myeloid leukaemia and non-cancerous cells in vitro– a preliminary study [Abstract]. International Conference on African Development. Aston University, Birmingham 18 - 20 Jun 2025 Ghana Scholarly Society. pp. 101-101
Study on the structure-activity relationship of an antimicrobial peptide, Brevinin-2GUb, from the skin secretion of Hylarana guentheri
Lin, Y., Liu, S., Xi, X., Ma, C., Wang, L., Chen, X., Shi, Z., Chen, T., Shaw, C. and Zhou, M. 2021. Study on the structure-activity relationship of an antimicrobial peptide, Brevinin-2GUb, from the skin secretion of Hylarana guentheri. Antibiotics. 10 (8). https://doi.org/10.3390/antibiotics10080895
Brevinin-2GHk from Sylvirana guentheri and the design of truncated analogs exhibiting the enhancement of antimicrobial activity
Chen, G., Miao, Y., Ma, C., Zhou, M., Shi, Z., Chen, X., Burrows, J., Xi, X., Chen, T. and Wang, L. 2020. Brevinin-2GHk from Sylvirana guentheri and the design of truncated analogs exhibiting the enhancement of antimicrobial activity. Antibiotics. 9 (2). https://doi.org/10.3390/antibiotics9020085